Mante, Friend Rezel C.

HRN: 20-42-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
MUPIROCIN 2%, 15G (TUBE)
03/28/2024
04/04/2024
TOPICAL
15g
BID
Phlebitis
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: